We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-3.3%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.1B
AUM Growth
-$231M
Cap. Flow
-$49.5M
Cap. Flow %
-1.6%
Top 10 Hldgs %
20.37%
Holding
134
New
2
Increased
44
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
TKO icon
TKO Group
TKO
+$39.3M
2
PTEN icon
Patterson-UTI
PTEN
+$37.7M
3
CRNC icon
Cerence
CRNC
+$9.42M
4
JJSF icon
J&J Snack Foods
JJSF
+$4.66M
5
POOL icon
Pool Corp
POOL
+$4.65M

Sector Composition

Rank Sector Weight
1 Industrials 26.31%
2 Technology 18.46%
3 Healthcare 16.91%
4 Financials 12.39%
5 Consumer Discretionary 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
1
Huron Consulting
HURN
$2.71B
$92.5M 2.98%
888,220
-53,364
-6% -$5.08M
MTSI icon
2
MACOM Technology Solutions
MTSI
$17.4B
$72.1M 2.33%
884,260
-75,411
-8% -$5.58M
ACHC icon
3
Acadia Healthcare
ACHC
$2.55B
$68.1M 2.2%
968,912
-69,304
-7% -$5.18M
BDC icon
4
Belden
BDC
$3.97B
$62.7M 2.02%
649,426
-45,061
-6% -$4.21M
MMSI icon
5
Merit Medical Systems
MMSI
$4.82B
$62.6M 2.02%
906,763
-67,731
-7% -$4.87M
AER icon
6
AerCap
AER
$23.4B
$61M 1.97%
972,716
-4,693
-0.5% -$295K
AEIS icon
7
Advanced Energy
AEIS
$10.1B
$58.8M 1.9%
570,080
-39,568
-6% -$4.43M
CHE icon
8
Chemed
CHE
$7.16B
$52.7M 1.7%
101,312
-548
-0.5% -$285K
ITRI icon
9
Itron
ITRI
$4.48B
$50.7M 1.63%
836,886
-5,092
-0.6% -$350K
EFOR
10
Everforth Inc
EFOR
$960M
$50.6M 1.63%
618,905
-2,802
-0.5% -$223K
AIN icon
11
Albany International
AIN
$2.09B
$47.3M 1.53%
548,419
-2,415
-0.4% -$220K
HQY icon
12
HealthEquity
HQY
$8.71B
$45.4M 1.46%
621,034
+27,824
+5% +$1.88M
OII icon
13
Oceaneering
OII
$4.64B
$44.5M 1.44%
1,731,967
-13,097
-0.8% -$299K
KBR icon
14
KBR
KBR
$4.56B
$44.1M 1.42%
747,919
-38,779
-5% -$2.39M
DY icon
15
Dycom Industries
DY
$11.2B
$43.9M 1.42%
493,348
-231,183
-32% -$23.1M
PBH icon
16
Prestige Consumer Healthcare
PBH
$2.47B
$42.5M 1.37%
742,557
+17,432
+2% +$1.05M
MATW icon
17
Matthews International
MATW
$887M
$40.9M 1.32%
1,050,991
-4,644
-0.4% -$201K
CRI icon
18
Carter's
CRI
$1.43B
$40.2M 1.3%
582,000
-2,439
-0.4% -$174K
NBHC icon
19
National Bank Holdings
NBHC
$1.9B
$39.5M 1.27%
1,326,229
-13,875
-1% -$444K
FCN icon
20
FTI Consulting
FCN
$5.14B
$38.8M 1.25%
217,339
-7,875
-3% -$1.47M
AZEK
21
DELISTED
The AZEK Co
AZEK
$38.1M 1.23%
1,280,920
-4,964
-0.4% -$156K
ALE
22
DELISTED
Allete
ALE
$36.5M 1.18%
691,230
-7,187
-1% -$405K
BOX icon
23
Box
BOX
$4.49B
$36.3M 1.17%
1,498,588
-1,279
-0.1% -$36.5K
WAB icon
24
Wabtec
WAB
$49.3B
$36.1M 1.16%
339,574
-19,381
-5% -$2.16M
PTEN icon
25
Patterson-UTI
PTEN
$3.54B
$35.6M 1.15%
+2,574,386
New +$37.7M

Similar funds

Aristotle Capital Boston's Q3 2023 Portfolio in Review

As of Q3 2023, Aristotle Capital Boston held 134 positions worth $3.1B, down 6.9% from $3.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston's Q3 2023 filing shows 2 new, 44 increased, 83 reduced and 5 closed positions. Its largest new stake was TKO Group: 422,892 shares worth $35.5M. The largest sale was World Wrestling Entertainment, an estimated $46.2M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

  • Aristotle Capital Boston's largest Q3 2023 buy was TKO Group: 422,892 shares worth $35.5M.
  • Aristotle Capital Boston added most to Cerence in Q3 2023, an estimated $9.42M increase.
  • Aristotle Capital Boston's biggest Q3 2023 reduction was Dycom Industries, cutting an estimated $23.1M.
  • Aristotle Capital Boston fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $46.2M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.1B portfolio in Q3 2023.
  • Aristotle Capital Boston opened 2 new positions and closed 5 in Q3 2023.
  • Aristotle Capital Boston's portfolio value fell 6.9% quarter-over-quarter to $3.1B.

Based on Aristotle Capital Boston's 13F filing for Q3 2023, filed 14 Nov 2023.